Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
Nature Medicine|June 1, 2010
Basophils and the T helper 2 environment can promote the development of lupus nephritisNicolas Charles, Donna Hardwick, Eric Daugas, et al.
Nature Clinical Practice. Rheumatology|November 1, 2006
Diagnosis and treatment of vasculitis of the central nervous system in a patient with systemic lupus erythematosusNikolay P Nikolov, Janine A Smith, Nicholas J Patronas, et al.
Annals of the Rheumatic Diseases|February 9, 2018
Lupus Low Disease Activity State (LLDAS) attainment discriminates responders in a systemic lupus erythematosus trial: post-hoc analysis of the Phase IIb MUSE trial of anifrolumabEric F Morand, Teodora Trasieva, Anna Berglind, et al.
Journal of the American Society of Nephrology : JASN|March 20, 2009
Randomized, controlled trial of prednisone, cyclophosphamide, and cyclosporine in lupus membranous nephropathyHoward A Austin, Gabor G Illei, Michelle J Braun, et al.
Rheumatology (Oxford, England)|May 8, 2012
The expression of APRIL in Sjogren's syndrome: aberrant expression of APRIL in the salivary glandJelle L Vosters, Nienke Roescher, Eline J Polling, et al.
Annals of the Rheumatic Diseases|August 4, 2012
Impact of anti-interleukin-6 receptor blockade on circulating T and B cell subsets in patients with systemic lupus erythematosusYuko Shirota, Cheryl Yarboro, Randy Fischer, et al.
Blood|March 21, 2009
Selective expression of latency-associated peptide (LAP) and IL-1 receptor type I/II (CD121a/CD121b) on activated human FOXP3+ regulatory T cells allows for their purification from expansion culturesDat Q Tran, John Andersson, Donna Hardwick, et al.
The Journal of Rheumatology|February 5, 2002
Gelatinase expression and activity in the synovium and skin of patients with erosive psoriatic arthritisCarol A Hitchon, Carol L Danning, Gabor G Illei, et al.
Blood|February 11, 2005
Identification and characterization of circulating human transitional B cellsGary P Sims, Rachel Ettinger, Yuko Shirota, et al.
Plos One|May 19, 2011
Effect of soluble ICAM-1 on a Sjögren's syndrome-like phenotype in NOD mice is disease stage dependentNienke Roescher, Jelle L Vosters, Hongen Yin, et al.
Pageof 6